-
Investors Watch List: Alexion Pharmaceuticals (NASDAQ:ALXN), Incyte Corporation (NASDAQ:INCY), Oritani Financial Corp. (NASDAQ:ORIT), Time Inc. (NYSE:TIME), Sunstone Hotel Investors Inc. (NYSE:SHO)
On Thursday shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) closed at $162.96. Company’s sales growth for last 5 years was 42.00% and EPS growth for next 5 years is recorded as 24.99%. Citigroup Inc. set a $173.00 target price on Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) in a report issued on Thursday. The firm currently has a hold…
-
Active Stocks: Alexion Pharmaceuticals (NASDAQ:ALXN), Sony Corp (ADR) (NYSE:SNE), Microsoft Corporation (NASDAQ:MSFT), Aegerion Pharmaceuticals (NASDAQ:AEGR), MIND C.T.I., (NASDAQ:MNDO)
On Tuesday shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) closed at $171.08. Company’s sales growth for last 5 years was 42.00% and EPS growth for next 5 years is recorded as 24.64%. On April 23, Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced financial results for the three months ended March 31, 2015. The Company reported net product sales…
-
Top Wall Street Stories: United Continental Holdings (NYSE:UAL), Alexion Pharmaceuticals (NASDAQ:ALXN), CenterPoint Energy (NYSE:CNP), 8×8 Inc. (NASDAQ:EGHT), Box Ships (NYSE:TEU)
On Thursday shares of United Continental Holdings, Inc. (NYSE:UAL) closed at $62.80. Company’s sales growth for last 5 years was 19.00% and EPS growth for next 5 years is recorded as 37.03%. On Thursday, United Continental Holdings Inc (NYSE:UAL) reported its first-quarter profit. Its profit reached above expectations and cut its capacity forecast for 2015.…
-
Active Stocks to Watch: Forward Pharma A/S (NASDAQ:FWP), Alexion Pharmaceuticals (NASDAQ:ALXN), The Toronto-Dominion Bank (NYSE:TD), Pearson plc (NYSE:PSO), HFF (NYSE:HF)
On Monday shares of Forward Pharma A/S (NASDAQ:FWP) closed at $32.11. On 9 April, Forward Pharma A/S (NASDAQ:FWP) announced an agreement among all of its pre-IPO shareholders to voluntarily lock-up their shares for an additional 365 days beyond the expiration of the original IPO lock-up. These shareholders collectively account for over 75% of the Company’s…
-
Stocks to Watch: Concert Pharmaceuticals (NASDAQ:CNCE), Aerohive Networks (NYSE:HIVE), Alexion Pharmaceuticals (NASDAQ:ALXN), Pfizer Inc. (NYSE:PFE), Precision Castparts Corp. (NYSE:PCP)
On Monday shares of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) closed at $14.84. Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) announced that it will present a corporate overview at the 14th Annual Needham Healthcare Conference, Tuesday, April 14, 2015 at 4:20 p.m. ET at The Westin Grand Central Hotel in New York City. Aerohive Networks, Inc. (NYSE:HIVE) in last trading…
-
Why Need to Watch: Alexion Pharmaceuticals (NASDAQ:ALXN), Solar3D (NASDAQ:SLTD), Boston Scientific Corporation (NYSE:BSX), Financial Institutions Inc. (NASDAQ:FISI), OvaScience (NASDAQ:OVAS)
On Friday shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) closed at $180.59. Company’s sales growth for last 5 years was 42.00% and EPS growth for next 5 years is recorded as 24.73%. Cheshire’s Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) said William Keller has decided to retire from its board of directors after its May annual meeting. Solar3D, Inc.…
-
Hot News: Alexion Pharmaceuticals (NASDAQ:ALXN), Verizon Communications Inc. (NYSE:VZ), CorMedix (NYSEMKT:CRMD), Montpelier Re Holdings (NYSE:MRH), Cathay General Bancorp (NASDAQ:CATY)
On Wednesday shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) closed at $175.63. Company’s sales growth for last 5 years was 42.00% and EPS growth for next 5 years is recorded as 24.73%. Alexion Pharmaceuticals (NASDAQ:ALXN)‘s stock had its “buy” rating reiterated by research analysts at BTIG Research in a report released on Thursday. On last trading…
-
Why Making Dramatic Moves: Alexion Pharmaceuticals (NASDAQ:ALXN), Becton, Dickinson (NYSE:BDX), Walker & Dunlo (NYSE:WD), Brookdale Senior Living (NYSE:BKD), On Assignment (NYSE:ASGN)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) in last trading activity increased 3.15% to close at $184.12. Company weekly performance is 1.57% while its quarterly performance stands at -1.49%. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) is -9.43% away from its 52 week high. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced that management presented Barclays Capital Global Healthcare Conference in Miami on Thursday,…
-
Watch List: Alexion Pharmaceuticals (NASDAQ:ALXN), ZIOPHARM Oncology (NASDAQ:ZIOP), Target Corp. (NYSE:TGT), Questar Corporation (NYSE:STR), Capital Bank Financial Corp. (NASDAQ:CBF)
On Monday shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) closed at $178.50. Company’s sales growth for last 5 years was 42.00% and EPS growth for next 5 years is recorded as 25.24%. On March 07, Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced that researchers presented new data from a retrospective, multinational natural history study of children (symptom onset…
-
5 Stocks in Dramatic Moves: Endeavour Silver Corp. (NYSE:EXK), Cliffs Natural Resources (NYSE:CLF), Southwest Airlines (NYSE:LUV), Alexion Pharmaceuticals (NASDAQ:ALXN), Carolina Bank. (NASDAQ:CLBH)
Haywood Securities upgraded shares of Endeavour Silver Corp (NYSE:EXK) to a hold rating in a report issued on Friday. On Friday shares of Endeavour Silver Corp. (NYSE:EXK) closed at $1.96. Company’s sales growth for last 5 years was 47.80%. Cliffs Natural Resources Inc. (NYSE:CLF) announced that it has amended its previously announced private offers (the…